254 related articles for article (PubMed ID: 23885912)
1. Cryoablation versus radiofrequency ablation for renal tumor ablation: time to reassess?
Gervais DA
J Vasc Interv Radiol; 2013 Aug; 24(8):1135-8. PubMed ID: 23885912
[No Abstract] [Full Text] [Related]
2. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
Zhou W; Arellano RS
J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
Uhlig A; Uhlig J; Trojan L; Kim HS
J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
[TBL] [Abstract][Full Text] [Related]
5. Ablation of Small Renal Masses.
Abdelsalam ME; Ahrar K
Tech Vasc Interv Radiol; 2020 Jun; 23(2):100674. PubMed ID: 32591194
[TBL] [Abstract][Full Text] [Related]
6. Irreversible electroporation (IRE): a novel method for renal tissue ablation.
Tracy CR; Kabbani W; Cadeddu JA
BJU Int; 2011 Jun; 107(12):1982-7. PubMed ID: 21044244
[TBL] [Abstract][Full Text] [Related]
7. Image-guided ablation of renal cell carcinoma.
Hinshaw JL; Lee FT
Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):429-47, vi. PubMed ID: 15271364
[TBL] [Abstract][Full Text] [Related]
8. Image-guided ablation of renal cell carcinoma.
Wah TM
Clin Radiol; 2017 Aug; 72(8):636-644. PubMed ID: 28527529
[TBL] [Abstract][Full Text] [Related]
9. [Radiofrequency ablation as an alternative treatment for organ confined renal tumor].
Gallego Vilar D; José Povo Martin I; Miralles Aguado J; Garau Perelló C; Bosquet Sanz M; Gimeno Argente V; Cifrián M; García Vila J; Gallego Gómez J
Actas Urol Esp; 2010 Nov; 34(10):860-5. PubMed ID: 21159281
[TBL] [Abstract][Full Text] [Related]
10. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review.
Johnson DB; Solomon SB; Su LM; Matsumoto ED; Kavoussi LR; Nakada SY; Moon TD; Shingleton WB; Cadeddu JA
J Urol; 2004 Sep; 172(3):874-7. PubMed ID: 15310987
[TBL] [Abstract][Full Text] [Related]
11. Small renal tumors: natural history, observation strategies and emerging modalities of energy based tumor ablation.
Derweesh IH; Novick AC
Can J Urol; 2003 Jun; 10(3):1871-9. PubMed ID: 12892573
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous computed tomography-guided renal mass radiofrequency ablation versus cryoablation: doses of sedation medication used.
Truesdale CM; Soulen MC; Clark TW; Mondschein JI; Wehrenberg-Klee E; Malkowicz SB; Wein AJ; Guzzo TJ; Stavropoulos SW
J Vasc Interv Radiol; 2013 Mar; 24(3):347-50. PubMed ID: 23433410
[TBL] [Abstract][Full Text] [Related]
13. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma.
Takaki H; Soga N; Kanda H; Nakatsuka A; Uraki J; Fujimori M; Yamanaka T; Hasegawa T; Arima K; Sugimura Y; Sakuma H; Yamakado K
Radiology; 2014 Jan; 270(1):292-9. PubMed ID: 23925272
[TBL] [Abstract][Full Text] [Related]
15. Difference of opinion - Which is the best treatment on a 2 cm complete endophitic tumor on the posterior side of the left kidney? Opinion: Cryoablation.
Garcia RG
Int Braz J Urol; 2016; 42(1):3-7. PubMed ID: 27120776
[No Abstract] [Full Text] [Related]
16. Renal surgery--is technique more important than tumor or patient characteristics in preserving kidney function?
Goldfarb DA
J Urol; 2011 Feb; 185(2):383-4. PubMed ID: 21168169
[No Abstract] [Full Text] [Related]
17. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
[TBL] [Abstract][Full Text] [Related]
18. Bipolar versus multipolar radiofrequency (RF) ablation for the treatment of renal cell carcinoma: differences in technical and clinical parameters.
Sommer CM; Lemm G; Hohenstein E; Stampfl U; Bellemann N; Teber D; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
Int J Hyperthermia; 2013; 29(1):21-9. PubMed ID: 23311376
[TBL] [Abstract][Full Text] [Related]
19. Development of a research agenda for percutaneous renal tumor ablation: proceedings from a multidisciplinary research consensus panel.
Georgiades CS; Rodriguez R; Littrup PJ; Frangakis CE; Leveille R; Ahrar K; Atwell TD; Cadeddu J; Trimmer C; Durack JC; Hammers HJ; Meng MV; Raman S; Solomon SB; Zagoria RJ; McLennan G; Laberge JM; Gervais DA; Kee ST
J Vasc Interv Radiol; 2010 Dec; 21(12):1807-16. PubMed ID: 21111363
[No Abstract] [Full Text] [Related]
20. Percutaneous radiofrequency ablation of renal tumors in solitary kidney patients.
Jiménez E; Zurera L; Espejo JJ; Requena MJ; Campos P; Rodríguez de Tembleque L; Canis M
Arch Esp Urol; 2011; 64(1):51-8. PubMed ID: 21289386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]